查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球蛋白质组学市场：规模/份额/趋势分析（技术/试剂/软件/服务/应用程序/最终用户）、区域展望、竞争策略、分部预测（至 2030 年）
市场调查报告书
商品编码
1076147

全球蛋白质组学市场：规模/份额/趋势分析（技术/试剂/软件/服务/应用程序/最终用户）、区域展望、竞争策略、分部预测（至 2030 年）

Proteomics Market Size, Share & Trends Analysis By Technology, By Reagent, By Software & Service, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 240 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球蛋白质组学市场预计将以 15.2% 的复合年增长率增长，到 2030 年达到 925.5 亿美元。市场的主要驱动力是传染病的流行、癌症和遗传疾病的发病率增加，以及对蛋白质和基因测序研究的需求不断增长。

本报告分析了全球蛋白质组学市场，包括市场基本结构、主要影响因素、整体市场规模趋势展望（2019-2030），按技术、试剂和软件/我们正在按服务调查详细趋势、应用程序、最终用户和地区、新型冠状病毒感染 (COVID-19) 的影响以及主要公司的概况。

目录

第 1 章介绍

第 2 章调查方法

第 3 章执行摘要

第 4 章市场动态

  • 促进因素、抑制因素、机会和问题分析
  • 新冠肺炎 (COVID-19)：对蛋白质组学市场的影响

第 5 章市场波动因素及前景

  • SWOT分析
  • PESTEL 分析
  • 波特五力分析
  • 热图分析

第 6 章全球蛋白质组学市场：按技术分类（单位：100 万美元，2019-2030）

  • 光谱学
    • 质谱
    • 核磁共振波谱
    • CD光谱
  • 色谱法
    • 高效液相色谱
    • 离子色谱法
    • 亲和层析
    • 超临界流体色谱
  • 电泳
    • 凝胶电泳
    • 毛细管电泳
  • 蛋白质芯片
    • 生物芯片
    • 微阵列设备
  • X射线晶体结构分析
  • 表面等离子共振
  • 蛋白质组分

第 7 章全球蛋白质组学市场：按试剂（单位：100 万美元，2019-2030）

  • 免疫分析试剂
  • 光谱试剂
  • 色谱试剂
  • 蛋白质芯片试剂
  • X射线晶体结构分析试剂
  • 电泳试剂
  • 蛋白质分离试剂

第 8 章全球蛋白质组学市场：按软件/服务（单位：100 万美元，2019-2030）

  • 核心蛋白质组学服务
    • 蛋白质鑑定服务
    • 蛋白质表征服务
    • 定量蛋白质组学服务
    • 蛋白质纯化服务
    • 蛋白质测序服务
    • 定制化验服务
  • 生物资讯学软件服务
    • 生物资讯学软件
    • 生物资讯学工具
    • 生物资讯学数据库

第 9 章全球蛋白质组学市场：按用途分类（单位：100 万美元，2019-2030）

  • 临床诊断
    • 癌症
    • 传染病
    • 糖尿病
    • 神经紊乱
    • 免疫疾病
    • 心血管疾病
    • 其他临床诊断用途
  • 药物发现
    • 目标发现
    • 线索识别
    • 读取优化
    • 临床前研究
  • 其他用途

第 10 章全球蛋白质组学市场：按最终用户分类（单位：100 万美元，2019-2030）

  • 医院
  • 临床研究所
  • 製药公司
  • 学术研究
  • 其他最终用户

第 11 章全球蛋白质组学市场：按地区划分（单位：100 万美元，2019-2030）

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 中东/非洲
    • 沙特阿拉伯王国
    • 阿拉伯联合酋长国
    • 其他中东

第 12 章公司简介

  • Agilent Technologies、Inc.
    • 公司简介
    • 财务展望
    • 产品概览
    • 近期趋势
  • Applied Biomics, Inc.
  • Biognosys AG
  • Biomax Informatics AG
  • Bioproximity
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Creative Proteomics
  • Danaher Corporation
  • Eurofins Scientific
  • Fios Genomics Ltd.
  • GE Healthcare
  • GENEWIZ
  • HORIBA, Ltd.
  • Illumina, Inc.
  • Integrated Proteomics Applications
  • Luminex Corporation
  • Merck KGaA
  • MRM Proteomics Inc.
  • MS Bioworks LLC
  • PerkinElmer Inc.
  • Poochon Scientific, LLC
  • Promega Corporation
  • Proteome Factory AG
  • QIAGEN Bioinformatics
简介目录
Product Code: BIOT2225

The global proteomics market is projected to be worth USD 92.55 billion by 2030

According to SPER Market Research, the proteomics market is estimated to reach USD 92.55 billion by 2030 with a CAGR of 15.2%. The rising prevalence of infectious diseases has increased the demand for the study of proteins and gene sequencing. This study can help in developing novel treatments against viral diseases, cancer, and other genetic disorders.

Impact of COVID-19 on the proteomics Market

The COVID-19 pandemic has increased the focus on decoding 3d structures of SARS-CoV-2 proteins. In order to understand therapies against COVID-19, protein crystallization techniques have played a significant role to understand virus proteins and specific sites. This has impacted the proteomics market in positively and the marker has grown further.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered By Technology, By Reagents, By Software & Services, By Application, By End-User.

Geographies covered: North America, Europe, APAC, Latin America and the Middle East & Africa.

Companies Covered:

Agilent Technologies, Inc., Applied Biomics, Inc., Biognosys AG, Biomax Informatics AG, Bioproximity, Bio-Rad Laboratories, Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, Eurofins Scientific, Fios Genomics Ltd., GE Healthcare, GENEWIZ, HORIBA, Ltd., Illumina, Inc., Integrated Proteomics Applications, Luminex Corporation, Merck KGaA, MRM Proteomics Inc., MS Bioworks LLC, PerkinElmer Inc., Poochon Scientific, LLC, Promega Corporation, Proteome Factory AG, QIAGEN Bioinformatics

Driver: Rising incidence of cancer and genetic disorders

The incidence of cancer and geriatric disorders is rising creating an urgent need for better therapeutics. The recent discoveries around the sequencing of the human genome are helping in developing novel treatments by evaluating gene expression at the proteome level. The extraction of biological information in diseased patients can help in the development of novel treatments and thus can drive the proteomics market

Opportunity: Rising demand for nanoproteomics

Nanotechnology is gaining popularity in the plethora of applications in various industries. In proteomics, nanotechnology can be utilized to develop phosphoproteomics, nanostructured surfaces for protein separation, and detection techniques for biomarkers protein. The growth of nanoproteomics technology is providing growth opportunities to the proteomics market

Challenge: High cost of equipment

The research activities involved in proteomics & genomics involve highly expensive instruments and reagents. The cost of installation along with maintenance charges and indirect costs makes it very challenging for developing countries to adopt these technologies

Proteomics Market by Technology:

Based on technology, the market has been segmented into Spectroscopy (Mass Spectroscopy, NMR Spectroscopy, CD Spectroscopy), Chromatography (HPLC, Ion Chromatography, Affinity Chromatography, Supercritical Fluid Chromatography), Electrophoresis (Gel Electrophoresis, Capillary Electrophoresis), Protein Microarrays (Biochips [Lab-on-Chips, Protein Chips], Micrparray Instruments [Integrated Systems, Microarray Scanners, Arrayers]), X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation

Proteomics Market by Reagents:

Based on reagents, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents

Proteomics Market by Software & Services:

Based on software & services, the market is segmented into Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomic Services, Protein Purification Services, Protein Sequencing Services, Custom Assay Services), Bioinformatics Software & Services (Bioinformatics Software, Bioinformatics Tools, Bioinformatics Databases)

Proteomics Market by Application:

Based on application, the market is segmented into Clinical Diagnostics (Cancer, Infectious Diseases, Diabetes, Neurological Disorders, Immune Diseases, Cardiovascular Diseases, and Other Clinical Diagnostic Applications), Drug Discovery (Target Discovery, Lead Identification, Lead Optimization, Preclinical Studies), Other Application

Proteomics Market by End User:

Based on end-users, the market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical Companies, Academic Research Laboratories, and Other End Users.

Pharmaceutical & Biotechnological companies have the largest share of this market by the end-user due to rising public & private funding for proteomics & genomics research activities and rising outsourcing of research activities to CRO services associated with pharmaceutical companies

Proteomics Market by Region:

North America owns the largest share of this market owing to rising investments & funding, rising preference for high-quality research, focus on reproducibility in research, raising awareness for personalized medicines, and presence of leading players in this market

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary data
    • 2.1.2. Primary data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity, and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impact on the Proteomics Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL analysis
    • 5.2.1. Political landscape
    • 5.2.2. Economic landscape
    • 5.2.3. Social landscape
    • 5.2.4. Technological landscape
    • 5.2.5. Environmental landscape
    • 5.2.6. Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of Buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat map analysis

6. Global Proteomics Market, By Technology, 2019-2030 (USD Million)

  • 6.1. Spectroscopy
    • 6.1.1. Mass Spectroscopy
    • 6.1.2. NMR Spectroscopy
    • 6.1.3. CD Spectroscopy
  • 6.2. Chromatography
    • 6.2.1. HPLC
    • 6.2.2. Ion Chromatography
    • 6.2.3. Affinity Chromatography
    • 6.2.4. Supercritical Fluid Chromatography
  • 6.3. Electrophoresis
    • 6.3.1. Gel Electrophoresis
    • 6.3.2. Capillary Electrophoresis
  • 6.4. Protein Microarrays
    • 6.4.1. Biochips
      • 6.4.1.1. Lab-on-Chips
      • 6.4.1.2. Protein Chips
    • 6.4.2. Micrparray Instruments
      • 6.4.2.1. Integrated Systems
      • 6.4.2.2. Microarray Scanners
      • 6.4.2.3. Arrayers
  • 6.5. X-Ray Crystallography
  • 6.6. Surface Plasmon Resonance
  • 6.7. Protein Fractionation

7. Global Proteomics Market, By Reagents, 2019-2030 (USD Million)

  • 7.1. Immunoassay Reagents
  • 7.2. Spectroscopy Reagents
  • 7.3. Chromatography Reagents
  • 7.4. Protein Microarray Reagents
  • 7.5. X-Ray Crystallography Reagents
  • 7.6. Electrophoresis Reagents
  • 7.7. Protein Fractionation Reagents

8. Global Proteomics Market, By Software & Services, 2019-2030 (USD Million)

  • 8.1. Core Proteomics Services
    • 8.1.1. Protein Identification Services
    • 8.1.2. Protein Characterization Services
    • 8.1.3. Quantitative Proteomic Services
    • 8.1.4. Protein Purification Services
    • 8.1.5. Protein Sequencing Services
    • 8.1.6. Custom Assay Services
  • 8.2. Bioinformatics Software & Services
    • 8.2.1. Bioinformatics Software
    • 8.2.2. Bioinformatics Tools
    • 8.2.3. Bioinformatics Databases

9. Global Proteomics Market, By Application, 2019-2030 (USD Million)

  • 9.1. Clinical Diagnostics
    • 9.1.1. Cancer
    • 9.1.2. Infectious Diseases
    • 9.1.3. Diabetes
    • 9.1.4. Neurological Disorders
    • 9.1.5. Immune Diseases
    • 9.1.6. Cardiovascular Diseases
    • 9.1.7. Other Clinical Diagnostic Applications
  • 9.2. Drug Discovery
    • 9.2.1. Target Discovery
    • 9.2.2. Lead Identification
    • 9.2.3. Lead Optimization
    • 9.2.4. Preclinical Studies
  • 9.3. Other Application

10. Global Proteomics Market, By End User, 2019-2030 (USD Million)

  • 10.1. Hospitals
  • 10.2. Clinical Laboratories
  • 10.3. Pharmaceutical Companies
  • 10.4. Academic Research Laboratories
  • 10.5. Other End Users

11. Global Proteomics Market, By Region, 2019-2030 (USD Million)

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1. Agilent Technologies, Inc.
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Applied Biomics, Inc.
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Biognosys AG
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. Biomax Informatics AG
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Bioproximity
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Bio-Rad Laboratories, Inc.
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Bruker Corporation
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Creative Proteomics
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Danaher Corporation
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Eurofins Scientific
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. Fios Genomics Ltd.
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. GE Healthcare
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. GENEWIZ
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. HORIBA, Ltd.
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Illumina, Inc.
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16. Integrated Proteomics Applications
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17. Luminex Corporation
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18. Merck KGaA
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19. MRM Proteomics Inc.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20. MS Bioworks LLC
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21. PerkinElmer Inc.
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22. Poochon Scientific, LLC
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23. Promega Corporation
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24. Proteome Factory AG
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments
  • 12.25. QIAGEN Bioinformatics
    • 12.25.1. Company details
    • 12.25.2. Financial outlook
    • 12.25.3. Product summary
    • 12.25.4. Recent developments